Deals 2 days ago UCB Paid $1.15B for Neurona's Single-Dose Epilepsy Cell Therapy UCB paid up to $650m upfront, with up to $500m in future milestones, to buy Neurona Therapeutics in a deal valued at up to $1.15bn. deals
